Skip to main content

Case Comprehensive Cancer Center

cancer-cells-feat
Cancer Center Seminar Series: “Targeting actin-regulatory protein in clear cell renal cancer”
The Cancer Center Seminar Series will kick off Friday, Sept. 10, at noon in Wolstein Research Building Auditorium (1-413). Partha Roy, associate professor of bioengineering and pathology at the University of Pittsburgh, will present “Targeting actin-regulatory protein in clear cell renal…
IMG_1888.jpg
Case Comprehensive Cancer Center joins national effort urging vaccination to protect against HPV and other diseases
NCI-designated cancer centers, AACI members and other cancer centers and medical groups endorse HPV vaccination and cancer screening to eliminate cancers caused by the virus. The Case Comprehensive Cancer Center - a partnership of Case Western Reserve University, Cleveland Clinic and University…
zhao-jianjun.jpeg
NIH Award Advances Drug Discovery Research into Chemotherapy-Associated Kidney Injury
Jianjun Zhao, MD, PhD, has received a five-year, nearly $2.6 million grant from the National Cancer Institute, part of the National Institutes of Health, to investigate a new approach for treating chemotherapy-associated kidney damage. In study results published last year, Dr. Zhao and his team…
cancer-cells
Affordable Cancer Technology Conference
The Affordable Cancer Technology (ACT 2021) Conference is a global oncology virtual event open to the public for the first time Sept. 23–24. The focus will be the intersection of technological innovation, cancer research, and global disparities, and it will bring together researchers, public health…
tuohy-vincent.jpg
U.S. Patent Issued for Cleveland Clinic Ovarian Cancer Vaccine Technology
The U.S. Patent and Trademark Office has issued the first U.S. patent for a novel ovarian cancer vaccine technology developed by Cleveland Clinic researchers Vincent K. Tuohy, PhD, Suparna Mazumder, PhD, and Justin M. Johnson. The technology is licensed worldwide by Anixa Biosciences, Inc., a…
Haojia_Li.jpeg
AI Used to Confirm Role of Collagen Structure in Tissue for Predicting Aggressiveness of Tumors, Recurrence of Cancer
​Scientists in Anant Madabhushi's lab have used artificial intelligence (AI) to identify new biomarkers for breast cancer that can predict whether the cancer will return after treatment—and which can be identified from routinely acquired tissue biopsy samples of early-stage breast cancer. The…
madabhushi-anant-250x300.jpg
Madabhushi Named to The Pathologist Power List 2021
Anant Madabhushi, PhD, director of the Center for Computational Imaging and Personalized Diagnostics and member of the Cancer Imaging Program of the Case Comprehensive Cancer Center, was recognized by The Pathologist’s Power List for the third consecutive year. This list celebrates 100 influential…
Cleveland Clinic Caregiver Grants Fund Research of COVID-19 Vaccines in Cancer Patients, New Cancer Treatments
Charis Eng, MD, PhD and Vinod Labhasetwar, PhD were recently selected to receive July 2021 Cleveland Clinic Caregiver Catalyst Grants. The Caregiver Catalyst Grants program pools the gifts from thousands of generous Cleveland Clinic donors into a fund allocated to support caregivers’ innovative…
gene_stargardt
Study confirms effectiveness of new personalized approach for radiation therapy
Genomic-adjusted radiation dose beneficial as a pan-cancer predictor of radiation therapy efficacy 
Study Confirms Effectiveness of New Personalized Approach for Radiation Therapy
Researchers from the Case Comprehensive Cancer Center, Cleveland Clinic, Case Western Reserve University School of Medicine, and Moffitt Cancer Center have found that the genomic adjusted radiation dose (GARD) may be used to personalize radiotherapy (RT) to maximize the therapeutic effect of a…